• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于有效治疗甲癣的载有百里醌的不饱和脂肪酸脂质体水凝胶的配方与研发。

Formulation and development of thymoquinone-loaded ufasome hydrogel for effective treatment of onychomycosis.

作者信息

Ali Mohd Shoab, Rehman Urushi, Gupta Garima, Alsayari Abdulrhman, Wahab Shadma, Goh Khang Wen, Kesharwani Prashant

机构信息

Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.

Graphic Era Hill University, Dehradun, 248002, India.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 14. doi: 10.1007/s00210-025-04505-0.

DOI:10.1007/s00210-025-04505-0
PMID:40813484
Abstract

Chronic fungal nail infections like onychomycosis are challenging to treat due to drug resistance, long treatment durations, and poor nail penetration of conventional antifungals. Here, we report the formulation and evaluation of a thymoquinone-loaded ufasome hydrogel (TQ-UFs-Gel) designed for enhanced transungual delivery. TQ-UFs were prepared by thin-film hydration of sodium oleate and cholesterol, optimized via a central composite design to yield vesicles ~ 191.50 ± 0.23 nm in size with 80.05 ± 0.34% entrapment efficiency and PDI 0.18 ± 0.32. The hydrogel was formed by incorporating TQ-UFs into 1% Carbopol 940. Physicochemical characterization included pH, spreadability, viscosity, texture profile analysis, in vitro release (Franz diffusion), ex vivo bovine hoof permeation, nail clipping drug loading, and HET-CAM irritation testing. The optimized TQ-UFs-Gel exhibited shear-thinning behavior (viscosity 987 → 387 cP), pH 5.9 ± 0.23, spreadability 8.7 ± 0.12 cm, and firmness 191.7 g. In vitro release showed a biphasic profile (39.90% in 2 h; 90.10% in 24 h), fitting the Korsmeyer-Peppas model (R = 0.9537). Ex vivo studies demonstrated 95.20 ± 0.8% cumulative permeation and flux 3.29 µg/cm/h, versus 70.30 ± 0.2% and 2.97 µg/cm/h for control gel. Nail clipping analysis confirmed increased TQ loading (1.43 µg/mg vs. 0.68 µg/mg for free TQ). Antifungal assays against Trichophyton mentagrophytes showed a significant CFU reduction for TQ-UFs compared to free drug, and HET-CAM tests indicated minimal irritation (IrS 0.41 ± 1.20). TQ-UFs-Gel demonstrated sustained release, enhanced nail permeation, and antifungal activity with low irritation potential, supporting its potential as a transungual delivery system for onychomycosis treatment.

摘要

像甲癣这样的慢性真菌性指甲感染,由于耐药性、治疗时间长以及传统抗真菌药物的指甲穿透性差,治疗起来颇具挑战性。在此,我们报告了一种用于增强经指甲递送的载有百里醌的不饱和脂肪酸囊泡水凝胶(TQ-UFs-Gel)的配方及评估。TQ-UFs通过油酸钠和胆固醇的薄膜水化法制备,经由中心复合设计进行优化,得到大小约为191.50±0.23纳米的囊泡,包封率为80.05±0.34%,多分散指数为0.18±0.32。水凝胶是通过将TQ-UFs掺入1%的卡波姆940中形成的。物理化学特性包括pH值、铺展性、粘度、质地剖面分析、体外释放(弗兰兹扩散)、离体牛蹄渗透、指甲剪片药物负载以及鸡胚绒毛尿囊膜刺激试验。优化后的TQ-UFs-Gel表现出剪切变稀行为(粘度987→387厘泊),pH值为5.9±0.23,铺展性为8.7±0.12厘米,硬度为191.7克。体外释放呈现双相特征(2小时内释放39.90%;24小时内释放90.10%),符合Korsmeyer-Peppas模型(R = 0.9537)。离体研究表明累积渗透率为95.20±0.8%,通量为3.29微克/平方厘米/小时,而对照凝胶分别为70.30±0.2%和2.97微克/平方厘米/小时。指甲剪片分析证实TQ负载量增加(1.43微克/毫克,而游离TQ为0.68微克/毫克)。针对须癣毛癣菌的抗真菌试验表明,与游离药物相比,TQ-UFs的菌落形成单位显著减少,鸡胚绒毛尿囊膜试验表明刺激性极小(刺激指数0.41±1.20)。TQ-UFs-Gel显示出持续释放、增强的指甲渗透性和抗真菌活性,且刺激性低,这支持了其作为治疗甲癣的经指甲递送系统的潜力。

相似文献

1
Formulation and development of thymoquinone-loaded ufasome hydrogel for effective treatment of onychomycosis.用于有效治疗甲癣的载有百里醌的不饱和脂肪酸脂质体水凝胶的配方与研发。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 14. doi: 10.1007/s00210-025-04505-0.
2
Gallic acid loaded self-nano emulsifying hydrogel-based drug delivery system against onychomycosis.载有没食子酸的自纳米乳化水凝胶基药物递送系统用于治疗甲癣
Nanomedicine (Lond). 2024;19(25):2065-2083. doi: 10.1080/17435889.2024.2386923. Epub 2024 Aug 15.
3
Transfersome enhances nail penetration of antifungal drug and photosensitizer for chemo-photodynamic therapy of onychomycosis in a novel rat model.在一种新型大鼠模型中,传递体可增强抗真菌药物和光敏剂对指甲的渗透,用于甲癣的化学光动力治疗。
J Control Release. 2025 Sep 10;385:114029. doi: 10.1016/j.jconrel.2025.114029. Epub 2025 Jul 10.
4
Development and optimization of raloxifene hydrochloride loaded lipid nanocapsule based hydrogel for transdermal delivery.基于盐酸雷洛昔芬负载脂质纳米囊泡的水凝胶用于透皮给药的研发与优化。
Ther Deliv. 2025 Feb;16(2):139-154. doi: 10.1080/20415990.2025.2457312. Epub 2025 Jan 29.
5
Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Infection.质量源于设计辅助开发卢立康唑传递体凝胶用于治疗感染。
Assay Drug Dev Technol. 2024 Jan;22(1):1-17. doi: 10.1089/adt.2023.059. Epub 2023 Dec 29.
6
Gallic Acid-Loaded Transethosomal Gel for Enhanced Topical Delivery and Sustained Therapeutic Efficacy in Psoriasis Management: Formulation, Optimization, In Vitro and Ex Vivo Assessment.载没食子酸转质体凝胶用于增强局部给药及在银屑病治疗中的持续疗效:制剂、优化、体外和离体评估
AAPS PharmSciTech. 2025 Jul 4;26(6):183. doi: 10.1208/s12249-025-03179-4.
7
Development, Characterization, In Vitro, Ex Vivo, and Stability Evaluation of a Miconazole Nitrate Nanocrystal-loaded Hydrogel for Topical Application.用于局部应用的载硝酸咪康唑纳米晶体水凝胶的开发、表征、体外、离体及稳定性评价
Curr Med Chem. 2025 Jul 28. doi: 10.2174/0109298673339390250605054706.
8
Betulin-NLC-hydrogel for the Treatment of Psoriasis-like Skin Inflammation: Optimization, Characterisation, and In vitro and In vivo Evaluation.用于治疗银屑病样皮肤炎症的桦木醇纳米脂质载体水凝胶:优化、表征及体外和体内评价
Curr Drug Deliv. 2024 Oct 2. doi: 10.2174/0115672018329544240922151617.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Thymoquinone-loaded Nanosized Ethosomal-based Hydrogels: Their Preparation, Characterization, in Vitro, Ex Vivo, and Antimicrobial Evaluation against Staphylococcus aureus.负载百里醌的纳米脂质体水凝胶:其制备、表征、体外、离体及对金黄色葡萄球菌的抗菌评价
Curr Med Chem. 2025 Jan 23. doi: 10.2174/0109298673341004250101104428.

本文引用的文献

1
Multifunctional DNA hydrogels with light-triggered gas-therapy and controlled G-Exos release for infected wound healing.具有光触发气体疗法和可控G-外泌体释放功能的多功能DNA水凝胶用于感染伤口愈合
Bioact Mater. 2025 Jun 14;52:422-437. doi: 10.1016/j.bioactmat.2025.06.004. eCollection 2025 Oct.
2
Smart hydrogel: A new platform for cancer therapy.智能水凝胶:癌症治疗的新平台。
Adv Colloid Interface Sci. 2025 Jun;340:103470. doi: 10.1016/j.cis.2025.103470. Epub 2025 Mar 7.
3
Investigating the Potential of Ufasomes Laden with Nintedanib as an Optimized Targeted Lung Nanoparadigm for Accentuated Tackling of Idiopathic Pulmonary Fibrosis.
研究载有尼达尼布的优脂肪酸体作为优化的靶向肺部纳米范例用于强化治疗特发性肺纤维化的潜力。
Pharmaceuticals (Basel). 2024 Nov 28;17(12):1605. doi: 10.3390/ph17121605.
4
Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids.用于递送核酸的细胞外囊泡与脂质纳米颗粒
Adv Drug Deliv Rev. 2024 Dec;215:115461. doi: 10.1016/j.addr.2024.115461. Epub 2024 Oct 28.
5
Sinapic-Acid-Loaded Nanoparticles Optimized via Experimental Design Methods: Cytotoxic, Antiapoptotoic, Antiproliferative, and Antioxidant Activity.通过实验设计方法优化的芥子酸负载纳米颗粒:细胞毒性、抗凋亡、抗增殖和抗氧化活性
ACS Omega. 2024 Sep 17;9(39):40329-40345. doi: 10.1021/acsomega.4c00216. eCollection 2024 Oct 1.
6
Gallic acid loaded self-nano emulsifying hydrogel-based drug delivery system against onychomycosis.载有没食子酸的自纳米乳化水凝胶基药物递送系统用于治疗甲癣
Nanomedicine (Lond). 2024;19(25):2065-2083. doi: 10.1080/17435889.2024.2386923. Epub 2024 Aug 15.
7
Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.甲癣的治疗选择:疗效、副作用、依从性、经济考量及伦理问题
J Clin Aesthet Dermatol. 2024 Mar;17(3):24-33.
8
Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes.治疗甲癣的抗真菌药物选择:患者考量与治疗结果
Infect Drug Resist. 2024 Mar 4;17:819-843. doi: 10.2147/IDR.S431526. eCollection 2024.
9
Hesperidin-loaded cubogel as a novel therapeutic armamentarium for full-thickness wound healing.载橘皮苷立方凝胶作为全层伤口愈合的新型治疗手段。
Colloids Surf B Biointerfaces. 2024 Feb;234:113728. doi: 10.1016/j.colsurfb.2023.113728. Epub 2023 Dec 26.
10
Potential Pharmacological Applications of Seeds with a Focus on and Its Constituents against Chronic Inflammatory Diseases: Progress and Future Opportunities.以[具体内容]及其成分对抗慢性炎症性疾病的种子的潜在药理学应用:进展与未来机遇
Plants (Basel). 2023 Nov 11;12(22):3829. doi: 10.3390/plants12223829.